Tecadenoson
CAS: 204512-90-3
Ref. 3D-EIA51290
5mg | 136,00 € | ||
10mg | 138,00 € | ||
25mg | 194,00 € | ||
50mg | 310,00 € | ||
100mg | 437,00 € |
Produktinformation
- (2R,3R,4S,5R)-2-(Hydroxymethyl)-5-[6-[tetrahydrofuran-3(R)-ylamino]-9H-purin-9-yl]tetrahydrofuran-3,4-diol
- Adenosine, N-[(3R)-tetrahydro-3-furanyl]-
- Cvt-510
- N-[(3R)-Tetrahydro-3-furanyl]adenosine
- N-[(3R)-tetrahydrofuran-3-yl]adenosine
Tecadenoson is an analog of adenosine. It has been shown to have synergistic effects in treating congestive heart failure and inflammatory bowel disease due to its ability to act on receptors. Tecadenoson has also been shown to increase blood flow in the bowel, which can be used for the treatment of bowel diseases such as Crohn's disease. Tecadenoson works by activating two types of receptors: A1 and A2A. Activation of these receptors leads to increased blood supply, which improves symptoms in patients with chronic obstructive pulmonary disease. Tecadenoson has also been shown to reduce inflammation and improve lung function in animal models of asthma. Tecadenoson is not active against bacterial infections or viral infections, but is effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and vasculitis.
Chemische Eigenschaften
Technische Anfrage zu: 3D-EIA51290 Tecadenoson
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.